Patent holdings for IPC class A61K 31/451

Total number of patents in this class: 889

10-year publication summary

63
71
81
88
72
100
87
67
61
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Prilenia Neurotherapeutics Ltd.
88
65
ChemoCentryx, Inc.
393
37
Takeda Pharmaceutical Company Limited
2943
16
Pacira Pharmaceuticals, Inc.
96
15
H. Lundbeck A/S
1249
14
Bristol-myers Squibb Company
4863
12
Amgen Inc.
3899
12
The University of Chicago
1360
12
AstraZeneca AB
2958
11
Teoxane
42
9
Teva Pharmaceuticals USA, Inc.
969
9
Novartis AG
11254
8
Janssen Pharmaceutica N.V.
3612
8
Toray Industries, Inc.
6855
8
Purdue Pharma L.P.
512
8
Teva Pharmaceuticals International GmbH
382
8
Remedy Pharmaceuticals, Inc.
40
7
The Regents of the University of California
19517
6
Daiichi Sankyo Company, Limited
1864
6
Kyushu University, National University Corporation
1627
6
Other owners 612